According to the latest report by IMARC Group “Medical Thawing System Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, The global medical thawing system market size reached US$ 191.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 301.5 Million by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028.

A medical thawing system refers to a system that is utilized to defrost biological samples for cell biology research. It uses microprocessors to regulate temperatures and cryopreserve ovum, semen, embryos, and other samples. Medical thawing systems assist in thawing live biological content to retain reproducibility and minimize the risk of contamination. They are primarily used during the transportation and storage of pharmaceutical products in the biopharmaceutical industry. Medical thawing systems are also widely adopted in blood banks, hospitals, tissue banks, biotech companies, etc.

Request for a free sample copy of this report:

Market Trends:

The growing number of individuals suffering from chronic diseases and viral and bacterial infections is one of the key factors driving the medical thawing system market. In line with this, the expanding geriatric population, which is more susceptible to such ailments and frequently undergoes surgical procedures, is propelling the demand for tissue transplantation. This, in turn, is further catalyzing the market growth. Moreover, the rising adoption of medical thawing systems to harvest and store skins, cornea, tendons, bone joints, cartilages, etc., is augmenting the global market. Besides this, the increasing need for tissue banks to collect tissue specimens and analyze cellular responses to infections is acting as another significant growth-inducing factor. Furthermore, the elevating adoption of regenerative medicines and personalized treatments across countries is projected to fuel the medical thawing system market over the forecasted period.

Breakup by Product Type:

  • Manual
  • Automated

Breakup by Sample Type:

  • Blood
  • Plasma
  • Stem Cells
  • Whole Blood
  • Platelets
  • Embryo
  • Ovum
  • Semen

Breakup by End User:

  • Blood Banks
  • Hospitals
  • Tissue Banks
  • Pharmaceutical and Biotech Companies
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Barkey GmbH & Co. KG
  • Biolife Solutions Inc.
  • Boekel Scientific
  • Cardinal Health Inc.
  • General Electric Company
  • Helmer Scientific Inc.
  • Hospicare Systems
  • labcold Limited
  • MMS Medical and Laboratory Supplies
  • Sarstedt AG & Co. KG
  • Sartorius AG
  • Terumo Penpol Private Limited (Terumo Corporation) and Thermo Fisher Scientific Inc.

Ask Analyst for Customization and Browse full report with TOC & List of Figure:

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US



USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA 

Follow us on Twitter: @imarcglobal